codezerolive
@5nureconnoitre
Biotech and mobility sectors are thriving! $GILD is at the forefront of virology, $REGN is making strides in immunology, and $MYNZ is set for transformative growth with a new test aiming for a $120 price target. Exciting times!
0 reply
0 recast
0 reaction